Association of anemia with health-related quality of life and survival: A large population-based cohort study

Haematologica

Volumn 104, Issue 3, 2019, Pages 468-476

  Wouters, Hanneke J C M ^a   van der Klauw, Melanie M ^a   de Witte, Theo ^b   Stauder, Reinhard ^c   Swinkels, Dorine W ^b,d   Wolffenbuttel, Bruce H R ^a   Huls, Gerwin ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d Hepcidinanalysiscom   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FOLIC ACID; HEPCIDIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CYANOCOBALAMIN DEFICIENCY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID DEFICIENCY; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; OVERALL SURVIVAL; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SOCIAL INTERACTION; SURVIVAL; ADOLESCENT; HEALTH SURVEY; KAPLAN MEIER METHOD; MORTALITY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; YOUNG ADULT;

EID: 85063871444     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2018.195552     Document Type: Article

References (45)

1. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009;12(4):444-454.
2. Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of popula-tion-representative data. Lancet Glob Health. 2013;1(1):e16-25.
3. Gaskell H, Derry S, Moore A, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr. 2008;8:1.
4. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8): 2263-2268.
5. Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53(12):2106-2111.
6. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52(5):719-724.
7. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006;107(10):3841-3846.
8. Dharmarajan TS, Pankratov A, Morris E, et al. Anemia: its impact on hospitalizations and length of hospital stay in nursing home and community older adults. J Am Med Dir Assoc. 2008;9(5):354-359.
9. Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006;61(5):474-479.
10. Halawi R, Moukhadder H, Taher A. Anemia in the elderly: a consequence of aging¿ Expert Rev Hematol. 2017;10(4):327-335.
11. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated¿ J Am Geriatr Soc. 2002;50(7):1257-1264.
12. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration¿ Blood. 2006;107(5):1747-1750.
13. Farag YM, Keithi-Reddy SR, Mittal BV, et al. Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol. 2011;75(6):524-533.
14. Ferrari M, Manea L, Anton K, et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:58.
15. Wasada I, Eguchi H, Kurita M, et al. Anemia affects the quality of life of Japanese cancer patients. Tokai J Exp Clin Med. 2013;38 (1):7-11.
16. Kraai IH, Luttik ML, Johansson P, et al. Health-related quality of life and anemia in hospitalized patients with heart failure. Int J Cardiol. 2012;161(3):151-155.
17. Stolk RP, Rosmalen JG, Postma DS, et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008;23 (1):67-74.
18. Klijs B, Scholtens S, Mandemakers JJ, Snieder H, Stolk RP, Smidt N. Representativeness of the LifeLines cohort study. PLoS One. 2015;10(9):e0137203.
19. VanderZee K I KI. Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996;3(2):104-122.
20. Blanc B, Finch CA, Hallberg L, et al. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5-37.
21. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44(1):45-51.
22. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-916.
23. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, et al. Immunochemical and mass-spec-trometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570-1579.
24. Ganji V, Kafai MR. Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US. Nutr Metab (Lond). 2012;9(1):2.
25. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8): 2263-2268.
26. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023.
27. Martinsson A, Andersson C, Andell P, Koul S, Engstrom G, Smith JG. Anemia in the general population: prevalence, clinical correlates and prognostic impact. Eur J Epidemiol. 2014;29(7):489-498.
28. Eisele L, Durig J, Broecker-Preuss M, et al. Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study. Ann Hematol. 2013;92(6):731-737.
29. Endres HG, Wedding U, Pittrow D, Thiem U, Trampisch HJ, Diehm C. Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. Curr Med Res Opin. 2009;25(5):1143-1158.
30. Stauder R, Thein SL. Anemia in the elderly: clinical implications and new therapeutic concepts. Haematologica. 2014;99(7):1127-1130.
31. Willems JM, den Elzen WP, Vlasveld LT, et al. No increased mortality risk in older persons with unexplained anaemia. Age Ageing. 2012;41(4):501-506.
32. Lucca U, Tettamanti M, Mosconi P, et al. Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study. PLoS One. 2008;3(4):e1920.
33. Thein M, Ershler WB, Artz AS, et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore). 2009;88(2): 107-114.
34. Bang SM, Lee JO, Kim YJ, et al. Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Ann Hematol. 2013;92(1):59-65.
35. Langer AL, Ginzburg YZ. Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation. Hemodial Int. 2017;21 (Suppl 1):S37-S46.
36. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023.
37. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50(12):1947-1954.
38. Olivares M, Hertrampf E, Capurro MT, Wegner D. Prevalence of anemia in elderly subjects living at home: role of micronutri-ent deficiency and inflammation. Eur J Clin Nutr. 2000;54(11):834-839.
39. Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia¿ Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health. 2008;11(1):57-75.
40. Roger SD, Jassal SV, Woodward MC, Soroka S, McMahon LP. A randomised sin-gle-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp(R) (darbe-poetin alfa) in older people: STIMULATE. Int Urol Nephrol. 2014;46(2):469-475.
41. Boccia R, Lillie T, Tomita D, Balducci L. The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia. Oncologist. 2007;12(5):584-593.
42. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55(10):1557-1565.
43. Vagetti GC, Barbosa Filho VC, Moreira NB, Oliveira V, Mazzardo O, Campos W. Association between physical activity and quality of life in the elderly: a systematic review, 2000-2012. Rev Bras Psiquiatr. 2014;36(1):76-88.
44. Molzahn A, Skevington SM, Kalfoss M, Makaroff KS. The importance of facets of quality of life to older adults: an international investigation. Qual Life Res. 2010;19(2):293-298.
45. Lee G, Choi S, Kim K, et al. Association of hemoglobin concentration and its change with cardiovascular and all-cause mortality. J Am Heart Assoc. 2018;7(3).